Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-10-29 00:00:00 ET · period of report 2024-10-28 · accession 0001649094-24-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-29 | 2024-10-28 | PCVX | Wassil Jim | COO | M - OptEx | $16.04 | +5,049 | 205.7K | +3% | +$81.0K |
| DM | 2024-10-29 | 2024-10-28 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -5,049 | 89.9K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-28 | M | A | 1,585 | $5.35 | 202,231 | D | — | — | (F1) Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024. |
| 2 | Common | Common Stock | 2024-10-28 | M | A | 3,464 | $20.93 | 205,695 | D | — | — | (F1) Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024. |
| 3 | Derivative | Stock Option (right to buy) | 2024-10-28 | M | D | 1,585 | $0.00 | 77,026 | D | $5.35 · — to 2030-04-17 | 1,585 Common Stock | (F2) Stock Option is fully vested and exercisable. |
| 4 | Derivative | Stock Option (right to buy) | 2024-10-28 | M | D | 3,464 | $0.00 | 89,876 | D | $20.93 · — to 2031-03-31 | 3,464 Common Stock | (F3) 1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |